Videofluorescence navigation during parenchymal-sparing liver resections using a domestic fluorescence imaging system

Close metadata

Recommended articles:

Implementation of fluorescent imaging technology in endovideosurgical treatment of colorectal endometriosis. Pirogov Russian Journal of Surgery. 2024;(5):129-136

Own experience of indocyanine green use in the diagnosis and treatment of breast cancer in N.N. Petrov NMRC of Oncology. Pirogov Russian Journal of Surgery. 2024;(7):111-114

ICG angiography is a safety standard in bariatric surgery. Pirogov Russian Journal of Surgery. 2024;(7):115-123

Indocyanine green is an integral part of breast reconstructive surgery using perforator flaps. Pirogov Russian Journal of Surgery. 2024;(8):34-40

Experience of indocyanine green use in acute calculous cholecystitis. Pirogov Russian Journal of Surgery. 2024;(8):52-56

Diagnostic value of fluorescence lymphography for sentinel lymph node biopsy in breast cancer. Summary experience of several specialized centers. Pirogov Russian Journal of Surgery. 2024;(10):49-61

Comparative analysis of laparoscopic cholecystectomy outcomes in acute calculous cholecystitis: importance of indocyanine green, optimal dosing regimen. Pirogov Russian Journal of Surgery. 2024;(11):72-76

Preliminary results of fluorescent lymphography in patients with biliary cancer undergoing liver resection. Pirogov Russian Journal of Surgery. 2025;(2):27-36

Parenchyma- sparing liver resections are aimed at maximizing the possible preservation of parenchyma not affected by the tumor — a current trend in hepatopancreatobiliary surgery. On the other hand, a prerequisite for operations is to ensure their radicality. To effectively solve this problem, all diagnostic imaging methods available in the arsenal are used, which make it possible to comprehensively solve the issues of perioperative planning of the volume and technical features of the planned operation. Diagnostic imaging methods that allow intraoperative navigation through intraoperative, instrumentally based determination of the tumor border and resection plane have additional value. One of the methods of such mapping is ICG video fluorescence intraoperative navigation. An analysis of the clinical use of the domestic video fluorescent navigation system “MARS” for parenchymal-sparing resections of focal liver lesions is presented. An assessment was made of the dynamics of the distribution of the contrast agent during ICG videofluorescent mapping during parenchymal-sparing resection interventions on the liver, with the analysis of materials from histological examination of tissues taking into account three-zonal videofluorescent marking of the resection edge, performed using the domestic videofluorescence imaging system «MARS».

Keywords:

video fluorescence navigation

parenchyma-sparing liver resections

fluorescent imaging system

indocyan green

parenchyma-sparing surgery

surgical clearance

liver metastases

intraoperative navigation

perioperative planning

Authors:

Semenkov A.V.

Moscow Regional Research and Clinical Institute («MONIKI»);
I.M. Sechenov First Moscow State Medical University

ORCID: 0000-0002-7365-6081

Subbot V.S.

I.M. Sechenov First Moscow State Medical University

ORCID: 0000-0002-7834-7819

Yuriev D.Y.

Moscow Regional Research and Clinical Institute («MONIKI»)

ORCID: 0009-0003-2374-3114

Received:

26.03.2024

Accepted:

10.04.2024

List of references:

Evrard S, Torzilli G, Caballero C, Bonhomme B. Parenchymal sparing surgery brings treatment of colorectal liver metastases into the precision medicine era. European Journal of Cancer. 2018;104:195-200. https://doi.org/10.1016/j.ejca.2018.09.030
Torzilli G, McCormack L, Pawlik T. Parenchyma-sparing liver resections. International Journal of Surgery. 2020;82S:192-197. https://doi.org/10.1016/j.ijsu.2020.04.047
Deng G, Li H, Jia GQ, Fang D, Tang YY, Xie J, Chen KF, Chen ZY. Parenchymal-sparing versus extended hepatectomy for colorectal liver metastases: A systematic review and meta-analysis. Cancer Medicine. 2019;8(14):6165-6175. https://doi.org/10.1002/cam4.2515
Viganò L, Torzilli G, Troisi R, Aldrighetti L, Ferrero A, Majno P, Toso C, Figueras J, Cherqui D, Adam R, Kokudo N, Hasegawa K, Guglielmi A, Krawczyk M, Giuliante F, Hilal MA, Costa-Maia J, Pinna AD, Cescon M, De Santibanes E, Urbani L, Pawlik T, Costa G, Zugna D; CLISCO group. Minor Hepatectomies: Focusing a Blurred Picture: Analysis of the Outcome of 4471 Open Resections in Patients Without Cirrhosis. Annals of Surgery. 2019;270(5):842-851. https://doi.org/10.1097/SLA.0000000000003493
Gold JS, Are C, Kornprat P, Jarnagin WR, Gönen M, Fong Y, DeMatteo RP, Blumgart LH, D’Angelica M. Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients. Annals of Surgery. 2008;247(1):109-17. https://doi.org/10.1097/SLA.0b013e3181557e47
Desjardin M, Desolneux G, Brouste V, Degrandi O, Bonhomme B, Fonck M, Becouarn Y, Béchade D, Evrard S. Parenchymal sparing surgery for colorectal liver metastases: The need for a common definition. European Journal of Surgical Oncology. 2017;43(12):2285-2291. https://doi.org/10.1016/j.ejso.2017.10.209
Donadon M, Cescon M, Cucchetti A, Cimino M, Costa G, Pesi B, Ercolani G, Pinna AD, Torzilli G. Parenchymal-Sparing Surgery for the Surgical Treatment of Multiple Colorectal Liver Metastases Is a Safer Approach than Major Hepatectomy Not Impairing Patients’ Prognosis: A Bi-Institutional Propensity Score-Matched Analysis. Digestive Surgery. 2018;35(4):342-349. https://doi.org/10.1159/000479336
Lordan JT, Roberts JK, Hodson J, Isaac J, Muiesan P, Mirza DF, Marudanayagam R, Sutcliffe RP. Case-controlled study comparing peri-operative and cancer-related outcomes after major hepatectomy and parenchymal sparing hepatectomy for metastatic colorectal cancer. HPB. 2017;19(8):688-694. https://doi.org/10.1016/j.hpb.2017.04.007
Matsuki R, Mise Y, Saiura A, Inoue Y, Ishizawa T, Takahashi Y. Parenchymal-sparing hepatectomy for deep-placed colorectal liver metastases. Surgery. 2016;160(5):1256-1263. https://doi.org/10.1016/j.surg.2016.06.041
Memeo R, de Blasi V, Adam R, Goéré D, Azoulay D, Ayav A, Gregoire E, Kianmanesh R, Navarro F, Sa Cunha A, Pessaux P; French Colorectal Liver Metastases Working Group, Association Française de Chirurgie (AFC). Parenchymal-sparing hepatectomies (PSH) for bilobar colorectal liver metastases are associated with a lower morbidity and similar oncological results: a propensity score matching analysis. HPB. 2016;18(9):781-790. https://doi.org/10.1016/j.hpb.2016.06.004
Mise Y, Aloia TA, Brudvik KW, Schwarz L, Vauthey JN, Conrad C. Parenchymal-sparing Hepatectomy in Colorectal Liver Metastasis Improves Salvageability and Survival. Annals of Surgery. 2016;263(1):146-152. https://doi.org/10.1097/SLA.0000000000001194
Torzilli G, Procopio F, Botea F, Marconi M, Del Fabbro D, Donadon M, Palmisano A, Spinelli A, Montorsi M. One-stage ultrasonographically guided hepatectomy for multiple bilobar colorectal metastases: a feasible and effective alternative to the 2-stage approach. Surgery. 2009;146(1):60-71. https://doi.org/10.1016/j.surg.2009.02.017
Donadon M, Torzilli G. Intraoperative ultrasound in patients with hepatocellular carcinoma: from daily practice to future trends. Liver Cancer. 2013;2(1):16-24. https://doi.org/10.1159/000346421
Cauchy F, Aussilhou B, Dokmak S, Fuks D, Gaujoux S, Farges O, Faivre S, Lepillé D, Belghiti J. Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases. Annals of Surgery. 2012;256(5):746-752; discussion 752-754. https://doi.org/10.1097/SLA.0b013e3182738204
Evrard S, Rivoire M, Arnaud J-, Lermite E, Bellera C, Fonck M, Becouarn Y, Lalet C, Puildo M, Mathoulin-Pelissier S. Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection. British Journal of Surgery. 2012;99(4):558-565. https://doi.org/10.1002/bjs.8724
Even Storli P, Johnsen G, Juel IS, Grønbech JE, Bringeland EA. Impact of increased resection rates and a liver parenchyma sparing strategy on long-term survival after surgery for colorectal liver metastases. A population-based study. Scandinavian Journal of Gastroenterology. 2019;54(7):890-898. https://doi.org/10.1080/00365521.2019.1641215
Kalil JA, Poirier J, Becker B, Van Dam R, Keutgen X, Schadde E. Laparoscopic Parenchymal-Sparing Hepatectomy: the New Maximally Minimal Invasive Surgery of the Liver-a Systematic Review and Meta-Analysis. Journal of Gastrointestinal Surgery. 2019;23(4):860-869. https://doi.org/10.1007/s11605-019-04128-w
Kazaryan AM, Aghayan DL, Barkhatov LI, Fretland ÅA, Edwin B. Laparoscopic Multiple Parenchyma-sparing Concomitant Liver Resections for Colorectal Liver Metastases. Surgical Laparoscopy Endoscopy and Percutaneous Techniques. 2019;29(3):187-193. https://doi.org/10.1097/SLE.0000000000000606
Okumura S, Tabchouri N, Leung U, Tinguely P, Louvet C, Beaussier M, Gayet B, Fuks D. Laparoscopic Parenchymal-Sparing Hepatectomy for Multiple Colorectal Liver Metastases Improves Outcomes and Salvageability: A Propensity Score-Matched Analysis. Annals of Surgical Oncology. 2019;26(13):4576-4586. https://doi.org/10.1245/s10434-019-07902-x
de Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Annals of Surgery. 2008;248(4):626-637. https://doi.org/10.1097/SLA.0b013e31818a07f1
Donadon M, Terrone A, Procopio F, Cimino M, Palmisano A, Viganò L, Del Fabbro D, Di Tommaso L, Torzilli G. Is R1 vascular hepatectomy for hepatocellular carcinoma oncologically adequate? Analysis of 327 consecutive patients. Surgery. 2019;165(5):897-904. https://doi.org/10.1016/j.surg.2018.12.002
Viganò L, Procopio F, Cimino MM, Donadon M, Gatti A, Costa G, Del Fabbro D, Torzilli G. Is Tumor Detachment from Vascular Structures Equivalent to R0 Resection in Surgery for Colorectal Liver Metastases? An Observational Cohort. Annals of Surgical Oncology. 2016;23(4):1352-1360. https://doi.org/10.1245/s10434-015-5009-y
Torzilli G, Viganò L, Fontana A, Procopio F, Terrone A, Cimino MM, Donadon M, Del Fabbro D. Oncological outcome of R1 vascular margin for mass-forming cholangiocarcinoma. A single center observational cohort analysis. HPB. 2020;22(4):570-577. https://doi.org/10.1016/j.hpb.2019.08.015
Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nature Reviews Cancer. 2007;7(11):834-846. https://doi.org/10.1038/nrc2256
Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Annals of Surgery. 2000;232(6):777-785. https://doi.org/10.1097/00000658-200012000-00006
Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley SA, Abdalla EK. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. Journal of Clinical Oncology. 2006;24(13):2065-2072. https://doi.org/10.1200/JCO.2005.05.3074
Kubo N, Araki K, Harimoto N, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Shirabe K. Hepatic resection for the right hepatic vein drainage area with indocyanine green fluorescent imaging navigation. Journal of Hepato-Biliary-Pancreatic Sciences. 2020;27(7):371-379. https://doi.org/10.1002/jhbp.728
Schwarz C, Plass I, Fitschek F, Punzengruber A, Mittlböck M, Kampf S, Asenbaum U, Starlinger P, Stremitzer S, Bodingbauer M, Kaczirek K. The value of indocyanine green clearance assessment to predict postoperative liver dysfunction in patients undergoing liver resection. Scientific Reports. 2019;9(1):8421. https://doi.org/10.1038/s41598-019-44815-x
Marino MV, Podda M, Fernandez CC, Ruiz MG, Fleitas MG. The application of indocyanine green-fluorescence imaging during robotic-assisted liver resection for malignant tumors: a single-arm feasibility cohort study. HPB. 2020;22(3):422-431. https://doi.org/10.1016/j.hpb.2019.07.013
Nomi T, Hokuto D, Yoshikawa T, Matsuo Y, Sho M. A Novel Navigation for Laparoscopic Anatomic Liver Resection Using Indocyanine Green Fluorescence. Annals of Surgical Oncology. 2018;25(13):3982. https://doi.org/10.1245/s10434-018-6768-z
Nakaseko Y, Ishizawa T, Saiura A. Fluorescence-guided surgery for liver tumors. Journal of Surgical Oncology. 2018;118(2):324-331. https://doi.org/10.1002/jso.25128
Peloso A, Franchi E, Canepa MC, Barbieri L, Briani L, Ferrario J, Bianco C, Quaretti P, Brugnatelli S, Dionigi P, Maestri M. Combined use of intraoperative ultrasound and indocyanine green fluorescence imaging to detect liver metastases from colorectal cancer. HPB. 2013;15(12):928-934. https://doi.org/10.1111/hpb.12057
Inoue Y, Tanaka R, Komeda K, Hirokawa F, Hayashi M, Uchiyama K. Fluorescence detection of malignant liver tumors using 5-aminolevulinic acid-mediated photodynamic diagnosis: principles, technique, and clinical experience. World Journal of Surgery. 2014;38(7):1786-1794. https://doi.org/10.1007/s00268-014-2463-9
Takasaki K. Glissonean pedicle transection method for hepatic resection: a new concept of liver segmentation. Journal of Hepato-Biliary-Pancreatic Surgery. 1998;5(3):286-291. https://doi.org/10.1007/s005340050047
CHERRICK GR, STEIN SW, LEEVY CM, DAVIDSON CS. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. The Journal of clinical investigation. 1960;39(4):592-600. https://doi.org/10.1172/JCI104072
Schwarz C, Plass I, Fitschek F, Punzengruber A, Mittlböck M, Kampf S, Asenbaum U, Starlinger P, Stremitzer S, Bodingbauer M, Kaczirek K. The value of indocyanine green clearance assessment to predict postoperative liver dysfunction in patients undergoing liver resection. Scientific Reports. 2019;9(1):8421. https://doi.org/10.1038/s41598-019-44815-x
Baker KJ. Binding of sulfobromophthalein (BSP) sodium and indocyanine green (ICG) by plasma alpha-1 lipoproteins. Proceedings of the Society for Experimental Biology and Medicine. 1966;122(4):957-963. https://doi.org/10.3181/00379727-122-31299
Aoki T, Yasuda D, Shimizu Y, Odaira M, Niiya T, Kusano T, Mitamura K, Hayashi K, Murai N, Koizumi T, Kato H, Enami Y, Miwa M, Kusano M. Image-guided liver mapping using fluorescence navigation system with indocyanine green for anatomical hepatic resection. World Journal of Surgery. 2008;32(8):1763-1767. https://doi.org/10.1007/s00268-008-9620-y
Ishizawa T, Fukushima N, Shibahara J, Masuda K, Tamura S, Aoki T, Hasegawa K, Beck Y, Fukayama M, Kokudo N. Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer. 2009;115(11):2491-2504. https://doi.org/10.1002/cncr.24291
Peyrat P, Blanc E, Guillermet S, Chen Y, Ferlay C, Perol D, Basso V, Rivoire M, Dupré A. HEPATOFLUO: A prospective monocentric study assessing the benefits of indocyanine green (ICG) fluorescence for hepatic surgery. Journal of Surgical Oncology. 2018;117(5):922-927. https://doi.org/10.1002/jso.25011
Abo T, Nanashima A, Tobinaga S, Hidaka S, Taura N, Takagi K, Arai J, Miyaaki H, Shibata H, Nagayasu T. Usefulness of intraoperative diagnosis of hepatic tumors located at the liver surface and hepatic segmental visualization using indocyanine green-photodynamic eye imaging. European Journal of Surgical Oncology. 2015;41(2):257-264. https://doi.org/10.1016/j.ejso.2014.09.008
Zhang YM, Shi R, Hou JC, Liu ZR, Cui ZL, Li Y, Wu D, Shi Y, Shen ZY. Liver tumor boundaries identified intraoperatively using real-time indocyanine green fluorescence imaging. Journal of Cancer Research Clinical Oncology. 2017;143(1):51-58. https://doi.org/10.1007/s00432-016-2267-4

Close metadata